Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015;40(1):115-6.
doi: 10.5114/ceji.2015.50843. Epub 2015 Apr 22.

Coexistence of hereditary angioedema in a case of familial Mediterranean fever with partial response to colchicine

Affiliations
Case Reports

Coexistence of hereditary angioedema in a case of familial Mediterranean fever with partial response to colchicine

Semiha Erdem Bahceci et al. Cent Eur J Immunol. 2015.

Abstract

Hereditary angioedema (HAE) is a very rare and potentially life-threatening genetic disease characterised by episodes of edema in various parts of the body, including the extremities, face, and airway. The disease is usually associated with attacks of abdominal pain. On the other hand, familial Mediterranean fever (FMF) is an inherited condition characterised by recurrent episodes of painful inflammation in the abdomen, chest, or joints. In this report, we present a child with FMF and undiagnosed HAE, which made him a partial responder to colchicine treatment. Consequently, HAE must be considered in differential diagnosis of cases in which a partial response is obtained from FMF treatment, particularly in countries where FMF is frequently encountered, because early diagnosis of HAE can facilitate prevention of life-threatening complications, such as upper airway obstruction. To our knowledge, our patient is the first patient reported in the literature with the diagnosis of HAE and FMF together.

Keywords: colchicine; familial Mediterranean fever; hereditary angioedema.

PubMed Disclaimer

Similar articles

Cited by

  • Colchicine in Managing Skin Conditions: A Systematic Review.
    Dastoli S, Nisticò SP, Morrone P, Patruno C, Leo A, Citraro R, Gallelli L, Russo E, De Sarro G, Bennardo L. Dastoli S, et al. Pharmaceutics. 2022 Jan 27;14(2):294. doi: 10.3390/pharmaceutics14020294. Pharmaceutics. 2022. PMID: 35214027 Free PMC article. Review.

References

    1. Temino VM, Peebles RS., Jr The spectrum and treatment of angioedema. Am J Med. 2008;121:282–286. - PubMed
    1. Bowen T, Cicardi M, Farkas H, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010;6:24. - PMC - PubMed
    1. Busse PJ. Angioedema: differential diagnosis and treatment. Allergy Asthma Proc. 2011;32(Suppl 1):3–11. - PubMed
    1. Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69:602–616. - PubMed
    1. Gavigan G, Yang WH, Santucci S, et al. The prophylactic use of C1 inhibitor in hereditary angioedema patients undergoing invasive surgical procedures: a retrospective study. Allergy Asthma Clin Immunol. 2014;10:17. - PMC - PubMed

Publication types

LinkOut - more resources